Hepatitis Clinical Trials in Chicago

Showing 21-40 of 242 trials

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

NCT02443116

The purpose of this study is to determine the safety, tolerability, and efficacy of NGM282 in patients with nonalcoholic steatohepatitis.

Nonalcoholic Steatohepatitis (NASH)

NGM Biopharmaceuticals, Inc254 participantsStarted Jul 2015

Chandler, Arizona, United States • Tucson, Arizona, United States • Los Angeles, California, United States +19 more locations

RECRUITING2.2 miles

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

NCT01644903

This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus) can be identified in its early stages. CKD damage to the kidneys, AR and HCV all lower the body's ability to function properly. Early detection of these conditions could assist with successful treatment and possibly lead to less repeat organ transplants.

Liver TransplantHepatitis CChronic Kidney Disease+1 more

Northwestern University1,000 participantsStarted Apr 2010

Chicago, Illinois, United States

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

Hepatitis Trials in Other Cities

Efficacy of Albumin Dialysis to Treat Patients With Hepatic Encephalopathy Using The Molecular Adsorbent Recirculating System (MARS)

A Phase 2b Study of Icosabutate in Fatty Liver Disease

A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis

Alcoholic Hepatitis Network Observational Study

A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis

A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

A Study of JNJ-73763989, Pegylated Interferon Alpha-2a, Nucleos(t)Ide Analog (NA) With or Without JNJ-56136379 in Treatment-naive Participants With Hepatitis B e Antigen (HBeAg) Positive Chronic Hepatitis B Virus (HBV) Infection

Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection

Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis

A Study in Participants With Non-cirrhotic NASH With Fibrosis

A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus

LITMUS Imaging Study

Other Conditions in Chicago